Proceedings

2017

2016

  • E. V. Maytin, S. Anand, “Combination photodynamic therapy using 5-fluorouracil and aminolevulinate enhances tumor-selective production of protoporphyrin IX and improves treatment efficacy of squamous skin cancers and precancers” Proc. SPIE  doi: 10.1117/12.2218138.
  • S. Anand, Erik Thomas, Tayyaba Hasan, Edward V. Maytin, “Vitamin D for combination photodynamic therapy of skin cancer in individuals with vitamin D deficiency: Insights from a preclinical study in a mouse model of squamous cell carcinoma” Proc. SPIE  doi: 10.1117/12.2214463.

2015

  • S. Lagnojita, J. T. Elliott, T. Hasan, B. W. Pogue, K. S. Samkoe, K. M. Tichauer, “Early photosensitizer uptake kinetics predict optimum drug-light interval for photodynamic therapy,” Proc. SPIE, 9308, 930811 (2015), doi: 10.1117/12.2077842.
  • E. V. Maytin, S. Anand, K. Rollakanti, “Clinical potential for vitamin D as a neoadjuvant for photodynamic therapy of nonmelanoma skin cancer,” Proc. SPIE, 9308, 93080H (2015), doi: 10.1117/12.2077234.
  • K. Rollakanti, S. Anand, E. V. Maytin, “Topical calcitrol prior to photodynamic therapy enhances treatment efficacy in non-melanoma skin cancer mouse models,” Proc. SPIE, 9308, 93080Q (2015), doi: 10.1117/12.2077296.
  • B. W. Pogue, S. Gioux, “Molecular-guided surgery,” Proc. SPIE, 9311, 931102-5, doi: 10.1117/12.2190063.

2014

2013

2012

2011

2010

2009

2008

2005-2007

  • E. V. Maytin, S. Anand, N. Sato, B. Moore, J. Mack, C. Gasbarre, S. Keevey, B. Ortel, A. Sinha, and A. Khachemoune, “Nuclear transcription factors: a new approach to enhancing cellular responses to ALA-mediated photodynamic therapy”, Proc. SPIE 6139, 613909 (2006), doi: 10.1117/12.646880.
  • E. V. Maytin, S. Anand, N. Sato, J. Mack, and B. Ortel, “Harnessing cellular differentiation to improve ALA-based photodynamic therapy in an artificial skin model”, Proc. SPIE 5689, 318 (2005), doi: 10.1117/12.601940.